LOGIN  |  REGISTER
Chimerix

Recent Insider Transactions - Keros Therapeutics (NASDAQ: KROS)

Follow NASDAQ:KROS Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ KROS Keros Therapeutics
ADAR1 Capital Management, LLC / 10 percent owner
04/09/2025
Buy
$10.33
74,333
$768K
4.39M
NASDAQ KROS Keros Therapeutics
ADAR1 Capital Management, LLC / 10 percent owner
04/09/2025
Buy
$10.33
500,000
$5.165M
4.32M
NASDAQ KROS Keros Therapeutics
ADAR1 Capital Management, LLC / 10 percent owner
04/09/2025
Buy
$9.86
325,000
$3.204M
3.82M
NASDAQ KROS Keros Therapeutics
ADAR1 Capital Management, LLC / 10 percent owner
04/09/2025
Buy
$9.40
18,560
$174K
3.49M
NASDAQ KROS Keros Therapeutics
ADAR1 Capital Management, LLC / 10 percent owner
04/09/2025
Buy
$9.40
16,365
$154K
743,558
NASDAQ KROS Keros Therapeutics
ADAR1 Capital Management, LLC / 10 percent owner
04/03/2025
Sell
$10.00
17,800
$178K
0
NASDAQ KROS Keros Therapeutics
Seehra Jasbir / director, officer: CHIEF EXECUTIVE OFFICER
04/04/2025
Buy
$0.30
49,367
$15K
302,223
NASDAQ KROS Keros Therapeutics
Seehra Jasbir / director, officer: CHIEF EXECUTIVE OFFICER
04/04/2025
Sell
$0.30
49,367
$15K
252,444

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous